Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

计划入组 316 人 · 首次发布于 2025 年 6 月 19 日

Study of MAR001 in Adults With Metabolic Dysfunction

计划入组 55 人 · 首次发布于 2023 年 6 月 9 日

A First-in-Human Study of BB-TL1A-VIAL-HLE in Healthy Adults and People With Ulcerative Colitis

计划入组 16 人 · 首次发布于 2025 年 6 月 19 日

MAR001

CD19 HLE BiTE

BCMA-CS1 HLE BiTE

HLT, Inc.

United States

KLE UNIVERSITY

India

PARK YONG HEE

France

Marea Therapeutics Reports Positive Phase 1 Results for MAR002 Acromegaly Treatment

Marea Therapeutics' MAR001 Shows Promise in Phase 2a Trial for Cardiovascular Disease; MAR002 for Acromegaly Advances

Lisata Acquires Marea Therapeutics in Stock-for-Stock Deal With $225 Million Concurrent Financing to Advance Cardioendocrine Pipeline